Lanean...
Decitabine enhances anti-CD33 monoclonal antibody BI 836858–mediated natural killer ADCC against AML blasts
Acute myeloid leukemia (AML) is the most common type of acute leukemia, affecting older individuals at a median age of 67 years. Resistance to intensive induction chemotherapy is the major cause of death in elderly AML; hence, novel treatment strategies are warranted. CD33-directed antibody-drug con...
Gorde:
Argitaratua izan da: | Blood |
---|---|
Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
American Society of Hematology
2016
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4900955/ https://ncbi.nlm.nih.gov/pubmed/27013443 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-11-680546 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|